AAD 2019: Systemic Glucocorticoid Therapy for More than 3 Months May Require Prophylaxis Against Bone Loss
Dermatologists should not shy away from bisphosphonate therapy, as benefits far outweigh risks
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.